Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia.
The chromosomal translocation t(15;17)(q22:21) of acute promyelocytic leukemia (APL) fuses PML, a novel gene, with RAR alpha, a retinoic acid receptor gene. PML-RAR hybrid transcripts were studied in 18 cases of APL using RNA-PCR. Two forms were noted: one designated 5', producing a 439-bp chimeric fragment, and a 3' form, producing a pair of fragments of 765 bp and 909 bp. 5' forms were found in 7 of the 18 cases while the other 11 patients expressed the 3' forms. The chromosome 15 specific probes K3 and K2 were used to study genomic breakpoints in 12 APL patients. Comparison of these results with RNA PCR in 11 patients for whom both were available yielded a rearrangement pattern predictive of whether the hybrid transcript was 5' or 3'. In this way, an additional three patients in whom DNA but not RNA was available were identified as having 3' (downstream) breakpoints and, therefore, 3' hybrid forms. Thus, 21 cases categorized as having 5' or 3' PML-RAR transcripts were analyzed for various phenotypic differences. Surface phenotyping of leukemic promyelocytes demonstrated expression of the CD2 antigen in all cases with the 5' splice variant. Only 1 of 11 cases with the 3' form showed CD2 expression. This difference is significant at P = .001.
Claxton
D F
DF
Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Reading
C L
CL
Nagarajan
L
L
Tsujimoto
Y
Y
Andersson
B S
BS
Estey
E
E
Cork
A
A
Huh
Y O
YO
Trujillo
J
J
Deisseroth
A B
AB
D000328:Adult; D015703:Antigens, CD / Q000235:genetics; D000945:Antigens, Differentiation, T-Lymphocyte / Q000235:genetics*; D015139:Blotting, Southern; D001853:Bone Marrow / Q000473:pathology; D018801:CD2 Antigens; D002352:Carrier Proteins / Q000235:genetics*; D002869:Chromosome Aberrations; D002884:Chromosomes, Human, Pair 15; D002886:Chromosomes, Human, Pair 17; D003001:Cloning, Molecular; D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D007621:Karyotyping; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D016133:Polymerase Chain Reaction / Q000379:methods; D011971:Receptors, Immunologic / Q000235:genetics*; D018168:Receptors, Retinoic Acid; D015183:Restriction Mapping; D013601:T-Lymphocytes / Q000276:immunology; D014158:Transcription, Genetic; D014178:Translocation, Genetic; D014212:Tretinoin / Q000378:metabolism
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D018801:CD2 Antigens; D002352:Carrier Proteins; D004273:DNA, Neoplasm; D011971:Receptors, Immunologic; D018168:Receptors, Retinoic Acid; D014212:Tretinoin